COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC:
Get the latest research information from NIH:

Coronavirus Guidance for NIH Applicants and Grantees:

Dr. Miriam Mintzer

Dr. Miriam Mintzer

Scientific Review Officer


Division of AIDS, Behavioral and Population Sciences DABP
Risk, Prevention and Health Behavior RPHB
Study Section:
Interventions to Prevent and Treat Addictions IPTA

Dr. Miriam Mintzer serves as the Scientific Review Officer for CSR’s Interventions to Prevent and Treat Addictions (IPTA) study section. After receiving her Ph.D. in experimental psychology (human memory and cognition) from New York University, Dr. Mintzer received postdoctoral training in the human behavioral pharmacology of substance abuse in the Department of Psychiatry at Johns Hopkins University School of Medicine, where she served as an associate professor prior to starting at CSR. Dr. Mintzer conducted NIH-funded research on the cognitive effects of drugs, and cognitive impairment and training interventions in a variety of clinical populations including adolescents and adults with addictions, older adults, and individuals with dementia. She was awarded five R01 and two R21 grants as principal investigator and has over 50 peer-reviewed scientific journal publications.